SYROS PHARMACEUTICALS, INC. Long-Term Debt
SYROS PHARMACEUTICALS, INC. had Long-Term Debt of $41.08 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2024-10-31
- 2024-09-30: Long-term Debt, Excluding Current Maturities $41.08M.
- 2024-06-30: Long-term Debt, Excluding Current Maturities $40.93M.
- 2024-03-31: Long-term Debt, Excluding Current Maturities $29.71M.
- 2023-12-31: Long-term Debt, Excluding Current Maturities $34.56M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2024-09-30 | $41.08M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $40.93M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $29.71M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $34.56M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $39.41M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $40.93M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $39.12M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $40.65M 10-K · filed 2024-03-27 |
| 2022-09-30 | $40.51M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $33.97M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $38.77M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $40.26M 10-K · filed 2023-03-02 |
| 2021-09-30 | $40.07M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $39.89M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $39.72M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $39.55M 10-K · filed 2022-03-15 |
| 2020-09-30 | $19.72M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $19.64M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $19.57M 10-Q · filed 2020-05-07 |